In the last sentence of the abstract on page 1575, the clinical trial number, #NCT00742027, should be #NCT01651039.
© 2022 by The American Society of Hematology
2022
Skip Nav Destination
ERRATUM|
November 22, 2022
Chari A, Cho HJ, Dhadwal A, et al. A phase 2 study of panobinostat with lenalidomide and weekly dexamethasone in myeloma. Blood Adv. 2017;1(19):1575-1583.
Blood Adv (2022) 6 (22): 5884.
